Source: Annual Congress 2006 - Pulmonary gas exchange
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Ergun, D. Ergun, S. Ardic, C. Ozdemir, M. Altinors, H. Firat, G. Darilmaz Yuce, M. B. Yuceege (Ankara, Turkey). The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease. Eur Respir J 2006; 28: Suppl. 50, 2399

Member's Comments

No comment yet.

Related content which might interest you: Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014 Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005 Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005 Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 439-443 Year: 2003 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2007; 29: 944-950 Year: 2007 Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007 Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005 Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Source: Eur Respir J 2011; 39: 119-124 Year: 2012 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Source: Eur Respir J 2012; 39: 119-124 Year: 2012 Effect of salbutamol on arterial blood gas tensions in patients with stable hypercapnic chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 16s Year: 2004 Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002 Non-invasive monitoring of carbon dioxide levels in patients using non-invasive ventilation for acute exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 549s Year: 2005 Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Noninvasive positive pressure ventilation using helium:oxygen versus air:oxygen in acute respiratory failure in chronic obstructive pulmonary disease patients exposed to sulfur mustard Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008 Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007